関連する実験動画
Updated: Jul 9, 2026

07:13
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
まとめ
Xamoterolは,心不全患者の臨床症状や運動能力を改善しませんでした. しかし,それは喘息を軽減しましたが,プラセボと比較して死亡リスクは増加しました.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
背景:
- 心不全 (HF) は,効果的な治療を必要とする複雑な症候群です.
- 利尿薬やACE阻害剤などの現在の治療法は,ニューヨーク心臓協会 (NYHA) のクラスIIIおよびIVHFの標準です.
- 新しい治療薬は,HFのアウトカムを改善するために継続的に調査されています.
研究 の 目的:
- 重度の心不全の患者におけるシャモテロールの有効性と安全性を評価する.
- 臨床的徴候,症状,運動能力,および死亡率に対するシャモテロールの影響を評価する.
主な方法:
- ダブルブラインドでグループ間の比較研究.
- NYHAクラスIII/IV心不全の患者516人がランダムに割り当てられました.
- 患者は,Xamoterol 200 mgまたはプラセボを1日2回,13週間にわたって受けました.
主要な成果:
- シャモテロール群とプラセボ群の臨床徴候の消失において有意な差異はありません.
- Xamoterolは呼吸困難の軽減を示しましたが,運動の持続時間や作業の改善はありませんでした.
- ザモテロールは心拍数と血圧を低下させ,心室の早拍数やリズム障害を引き起こす作用が増加しなかった.
- 治療の意図の分析は,Xamoterolグループで100日 (p=0.02) の間にプラセボ (3.7%) と比較して,Xamoterolグループで100日 (p=0.02) の間に著しく高い死亡率を示しました.
結論:
- シャモテロールは,重度の心不全患者の臨床的利益を示さなかった.
- シャモテロールは喘息を和らげるかもしれないが,死亡リスクの増加と関連している.
- 心不全におけるシャモテロールの安全性に関するさらなる調査が必要である.
関連する概念動画
Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

